The All India Institute of Medical Sciences, New Delhi and the Indian Institute of Technology Delhi have launched a ground-breaking new collaboration with University College London (UCL) to co-create pioneering solutions in the field of medical technology.
For the first time, the three institutions will join forces to draw on their complementary areas of expertise to develop new technologies that help tackle some of today's biggest health challenges
On November 22, 2024, AIIMS New Delhi, IIT Delhi and UCL signed a Memorandum of Understanding committing to partnership in research and innovation. The partnership, which will seek to leverage industry connections across all three institutions, will pave the way for devising multidisciplinary technology and innovation focused solutions across healthcare.
The partnership will be underpinned by development of staff and student exchange, joint research programmes, collaborative degrees, workshops and conferences, and joint publications.
Professor Alok Thakar, Head of Centre for Medical Innovation and Entrepreneurship (AIIMS), said, "This tripartite partnership between AIIMS, IIT Delhi, and UCL represents a transformative step in addressing some of the most pressing health and societal challenges. By combining our expertise in
medical science, engineering, and global policy, we are creating a platform for MedTech innovation. Together, we aim to develop impactful solutions, set new benchmarks in medical technology and interdisciplinary research, and enhance patient care delivery."
"IIT Delhi is excited to be working together with AIIMS and UCL in the area of medical technologies. We believe that science, engineering and medicine research and innovation can make a difference in people's lives by providing affordable healthcare. Our partnership is poised to make a difference through cost effective innovations in medical technology," Prof Rangan Banerjee, Director, IIT Delhi.
Together, the universities aim to advance the field of medical technology in cutting-edge areas such as detection, diagnostics and imaging; devices and implants; assistive technologies; digital health; artificial intelligence, machine learning and quantum; surgical and treatment interventions and sensing technologies.
Dr Michael Spence, UCL's President & Provost, said, "At UCL we recognise the difference that international collaboration can make to solving pressing global challenges and we know the power that bringing together different disciplines can have. We are honoured and excited to embark on this new partnership with two such renowned Indian institutions and know we will achieve great things together to make a real difference to people."
